In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Neratinib: inching up on the cure rate of HER2+ breast cancer?
Clin Cancer Res
©2019 American Association for Cancer Research.
American Association for Cancer Research.